5th International Conference on Heart and Cardiovascular Diseases

Southeast Asia joined the Heart Congress map in 2026. Held at the AC Hotel by Marriott, Kuala Lumpur, the 4th edition drew its broadest and most diverse speaker faculty to date -spanning five continents and bringing new regional voices into a scientific conversation that had been building since Dubai in 2023.

The 4th International Conference on Heart and Cardiovascular Diseases was successfully held on May 04-05, 2026, at Kuala Lumpur, Malaysia. Organized by Scientex Conferences, the event was conducted in a hybrid format, bringing together cardiologists, researchers, healthcare professionals, and industry experts from more than 20 countries. Under the theme, "Novel Progression Towards the Heart and Cardiovascular Research," the conference provided an international platform to discuss the latest advancements, innovative research, and emerging trends in cardiovascular science and patient care.

Heart Congress 2026 marked a significant milestone as the first edition hosted in Southeast Asia, expanding its global reach by welcoming new scientific contributions from Malaysia, Indonesia, and the Philippines. The conference fostered meaningful collaborations through keynote presentations, scientific sessions, and networking opportunitiesnes

Scientific Themes

Keynote Presentations:

• Terrance Khastgir (Integris Baptist Medical Center, USA) — Heart failure: an electrophysiology overview
• Tatsuya Nakao (New Tokyo Hospital, Japan) — 10 years of bloodless open cardiac surgery in Jehovah's Witness patients
• Zhongjian Li (Zhengzhou University, China) — ECG identification applied in the insurance industry
• Daniel Victor Ortigoza (Hospital de Morón, Argentina) — DOACs in elderly and frail patients with atrial fibrillation
• Anand Balaram Patil (Medicover Hospitals, Mumbai, India) — Supra-normal functional recovery following acute LAD stent thrombosis and VT storm

Clinical Topics Across the Programme:

• SAPIEN valve pathological assessment and 2-year TAVR-in-TAVR outcomes
• AI in chronic venous insufficiency management
• MicroRNA molecular calibration of the sinoatrial node
• Familial hypercholesterolaemia - emerging treatment options
• Goflikicept in idiopathic recurrent pericarditis - real-world data
• Paediatric cardiac surgery risk stratification in patients with comorbidities
• Cardiac arrest simulation using immersive technology
• Vitamin D and the cardiovascular system
• Ticagrelor versus clopidogrel in ACS patients on dialysis - meta-analysis

Returning Speakers Who Built on Previous Work:

• Gabriela Strey (Australia) — presenting at Heart Congress for the third time
• Alina Cornea (Ireland) — building on pulmonary hypertension and transplant research from prior editions
• Toru Ouchi and Toru Naganuma (New Tokyo Hospital, Japan) — continued TAVR outcome data

We also extend our sincere gratitude to Dr. Andrea Radyaputri, Universitas Gadjah Mada, Indonesia, for her excellent service as Moderator.

A Speaker's View

"Very nice to be a part of this Scientex conferences today, I had a very nice time, very nice deliberations by experts from all around the world. We have seen experts speak on various subjects. We have very nice discussions, very nice interactions from the great experts right from Japan to Philippines to UK to Russia from India. It is a very great learning experience for me as well."

— Surya Satya Gopal Palanki, Nizam’s Institute of Medical Sciences, India

What Came Next

Heart Congress 2026 closed with the announcement of the 5th International Conference on Heart and Cardiovascular Diseases, scheduled for April 22–23, 2027, in Paris, France.

Theme: Transforming Cardiovascular Care: Bridging Innovation, Research, and Clinical Excellence

The Paris edition marks a new chapter - a new continent, a new theme, and the next step in building a truly global cardiovascular science community.